ecancer

Aims and successes of the 2nd EurocanPlatform project translational research course

Christina von Gertten, Karolinska Institutet, Stockholm, Sweden

6 Jan 2015

The DNA damage response and cancer therapy

Dr Christopher Lord, The Institute of Cancer Research, London, UK

6 Jan 2015

New approaches and new partnership models for biomarker based clinical research

Dr Denis Lacombe, EORTC, Brussels, Belgium

6 Jan 2015

Patient and political advocacy in women's cancers

Sarah Goltz - Founder of Sage Innovation

18 Dec 2014

WHO guidelines on preventing and screening for cervical cancer

Dr Nathalie Broutet – World Health Organization, Geneva, Switzerland

18 Dec 2014

Comment: Combining tamoxifen with ovarian suppression reduced recurrence of some breast cancers

Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA

12 Dec 2014

Biomarker for PARP inhibitor responsiveness in ovarian cancer patients

Prof Elizabeth Swisher - University of Washington, Washington, USA

27 Nov 2014

Targeting PI3K in female cancers

Dr Lewis Cantley - Weill Cornell Medical College, New York, USA

10 Nov 2014

Research shows chemotherapy has no negative effects on babies in utero

Prof Frederic Amant - University Hospital Leuven, Leuven, Belgium

1 Oct 2014

Importance of gynaecological surgeons and multidisciplinary strategies in advanced ovarian cancer

Dr Lucas Minig - Valencia Institute of Oncology, Valencia, Spain

1 Oct 2014

Cediranib and chemo combo improves PFS for metastatic cervical cancer

Dr Raymond 'Paul' Symonds - University Hospital of Leicester, Leicester, UK

28 Sep 2014

Adding cediranib to chemo improves PFS for metastatic cervical cancer

Dr Paul Symonds - University Hospital of Leicester, Leicester, UK

28 Sep 2014

More from ecancer